Search research articles
Contact Us
Filters
Showing results (511-520 of 520) with videos related to
Page
of 52
Sort By:
You have reached the last page of results.
This site can display upto 520 results.
Cancers
|
February 13, 2025
<i>RET</i> C611Y Germline Variant in Multiple Endocrine Neoplasia Type 2A in Denmark 1930-2021: A Nationwide Study
Anders Würgler Hansen, Peter Vestergaard, Morten Møller Poulsen, et al.
Clinical Epidemiology
|
September 30, 2024
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Project Cohort and Biobank from 2010 Through 2023-A Cohort Profile Update
Frederik P B Kristensen, Sia K Nicolaisen, Jens S Nielsen, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2023
Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial
Julie Schjødtz Hansen, Stefan Gustavsen, Homayoun Roshanisefat, et al.
Endocrine-Related Cancer
|
April 26, 2017
Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study
Jes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
Stroke
|
November 9, 2013
Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial
Kristina Dupont Hougaard, Niels Hjort, Dora Zeidler, et al.
International Journal of Bipolar Disorders
|
December 22, 2022
Lithium induced hypercalcemia: an expert opinion and management algorithm
Zoltan Kovacs, Peter Vestergaard, Rasmus W Licht, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 2, 2018
International consensus on quality standards for brain health-focused care in multiple sclerosis
Jeremy Hobart, Amy Bowen, George Pepper, et al.
JAMA Neurology
|
June 12, 2023
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Izanne Roos, Stella Hughes, Gavin McDonnell, et al.
Frontiers in Neurology
|
January 8, 2024
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Tim Spelman, Melinda Magyari, Helmut Butzkueven, et al.
CNS Drugs
|
September 18, 2021
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
Sifat Sharmin, Mathilde Lefort, Johanna Balslev Andersen, et al.
Page
of 52
Search research articles
Search
Showing results (511-520 of 520) with videos related to
Sort By:
Page
of 52
You have reached the last page of results.
This site can display upto 520 results.
Cancers
|
February 13, 2025
<i>RET</i> C611Y Germline Variant in Multiple Endocrine Neoplasia Type 2A in Denmark 1930-2021: A Nationwide Study
Anders Würgler Hansen, Peter Vestergaard, Morten Møller Poulsen, et al.
Clinical Epidemiology
|
September 30, 2024
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Project Cohort and Biobank from 2010 Through 2023-A Cohort Profile Update
Frederik P B Kristensen, Sia K Nicolaisen, Jens S Nielsen, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2023
Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial
Julie Schjødtz Hansen, Stefan Gustavsen, Homayoun Roshanisefat, et al.
Endocrine-Related Cancer
|
April 26, 2017
Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study
Jes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
Stroke
|
November 9, 2013
Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial
Kristina Dupont Hougaard, Niels Hjort, Dora Zeidler, et al.
International Journal of Bipolar Disorders
|
December 22, 2022
Lithium induced hypercalcemia: an expert opinion and management algorithm
Zoltan Kovacs, Peter Vestergaard, Rasmus W Licht, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 2, 2018
International consensus on quality standards for brain health-focused care in multiple sclerosis
Jeremy Hobart, Amy Bowen, George Pepper, et al.
JAMA Neurology
|
June 12, 2023
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Izanne Roos, Stella Hughes, Gavin McDonnell, et al.
Frontiers in Neurology
|
January 8, 2024
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Tim Spelman, Melinda Magyari, Helmut Butzkueven, et al.
CNS Drugs
|
September 18, 2021
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
Sifat Sharmin, Mathilde Lefort, Johanna Balslev Andersen, et al.
Page
of 52